Quantum BioPharma Ltd. Finance Costs
Quantum BioPharma Ltd. (QNTM) reported Finance Costs of $158.06 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2026-03-26
CAD
| Period end | Finance Costs 12 month |
|---|---|
| 2019-12-31 | 206.45K CAD 40-F/A · filed 2020-03-17 |
USD
| Period end | Finance Costs 3 month | Finance Costs 3 month as first filed | Finance Costs 6 month | Finance Costs 6 month as first filed | Finance Costs 9 month | Finance Costs 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | -$72.64K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $18.93K derived: sum of 2 quarters · filed 2026-03-26 | $135.90K derived: sum of 3 quarters · filed 2026-03-26 | $158.06K 20-F · filed 2026-03-26 | ||
| 2025-09-30 | $91.57K 6-K · filed 2025-11-06 | $208.53K derived: sum of 2 quarters · filed 2025-11-06 | $230.70K 6-K · filed 2025-11-06 | $232.57K derived: sum of 4 quarters · filed 2026-03-26 | ||
| 2025-06-30 | $116.96K 6-K · filed 2025-08-07 | $139.13K 6-K · filed 2025-08-07 | $141.00K derived: sum of 3 quarters · filed 2026-03-26 | $151.38K derived: sum of 4 quarters · filed 2026-03-26 | ||
| 2025-03-31 | $22.17K 6-K/A · filed 2025-06-16 | $24.04K derived: sum of 2 quarters · filed 2026-03-26 | $34.41K derived: sum of 3 quarters · filed 2026-03-26 | $42.77K derived: sum of 4 quarters · filed 2026-03-26 | ||
| 2024-12-31 | $1.88K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $12.25K derived: sum of 2 quarters · filed 2026-03-26 | $20.60K derived: sum of 3 quarters · filed 2026-03-26 | $33.02K 20-F · filed 2026-03-26 | ||
| 2024-09-30 | $10.37K 6-K · filed 2025-11-06 | $18.73K derived: sum of 2 quarters · filed 2025-11-06 | $31.14K 6-K · filed 2025-11-06 | $31.15K derived: sum of 4 quarters · filed 2026-03-26 | ||
| 2024-06-30 | $8.36K 6-K · filed 2025-08-07 | -$8.36K 6-K/A · filed 2024-08-19 | $20.77K 6-K · filed 2025-08-07 | -$20.77K 6-K/A · filed 2024-08-19 | $20.78K derived: sum of 3 quarters · filed 2026-03-26 | $20.40K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-03-31 | $12.41K 6-K/A · filed 2025-06-16 | $12.43K derived: sum of 2 quarters · filed 2026-03-26 | $12.05K derived: sum of 3 quarters · filed 2026-03-26 | $12.05K derived: sum of 4 quarters · filed 2026-03-26 | ||
| 2023-12-31 | $12.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | -$368.00 derived: sum of 2 quarters · filed 2026-03-26 | -$368.00 derived: sum of 3 quarters · filed 2026-03-26 | $299.00 20-F · filed 2026-03-26 | ||
| 2023-09-30 | -$380.00 6-K · filed 2024-11-12 | -$380.00 derived: sum of 2 quarters · filed 2024-11-12 | $287.00 6-K · filed 2024-11-12 | |||
| 2023-06-30 | $0.00 6-K/A · filed 2024-08-19 | -$667.00 6-K/A · filed 2024-08-19 | ||||
| 2022-12-31 | $48.82K 20-F/A · filed 2025-03-31 | |||||
| 2021-12-31 | $69.40K 20-F · filed 2024-04-02 | |||||
| 2020-12-31 | $235.58K 20-F · filed 2023-03-31 | |||||
| 2019-12-31 | $155.32K 40-F · filed 2021-03-17 |